Articles by Mary R. Dicklin (6)

Effects of Prescription Omega-3-Acid Ethyl Esters Plus Simvastatin on Lipids and Lipoprotein Particles in Mixed Dyslipidemia

Kevin Carl Maki, Mary R. Dicklin, Barry C. Lubin, James M. McKenney and Matthew S. Reeves

Journal of Clinical Lipidology 2 ( 3 ): 222 - 223 , 2008

Prescription omega-3 acid ethyl esters plus simvastatin 20 and 80 mg: effects in mixed dyslipidemia

Kevin C. Maki, Barry C. Lubin, Matthew S. Reeves, Mary R. Dicklin and William S. Harris

Journal of Clinical Lipidology 3 ( 1 ): 33 - 38 , 2009

Predictors of anterior and posterior wall carotid intima media thickness progression in men and women at moderate risk of coronary heart disease

Kevin C. Maki, Michael H. Davidson, Mary R. Dicklin, Marjorie Bell, MarySue Witchger and Steven B. Feinstein

Journal of Clinical Lipidology 5 ( 3 ): 141 - 151 , 2011

Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists

Michael H. Davidson, Christie M. Ballantyne, Terry A. Jacobson, Vera A. Bittner, Lynne T. Braun, Alan S. Brown, W. Virgil Brown, William C. Cromwell, Ronald B. Goldberg, James M. McKenney, Alan T. Remaley, Allan D. Sniderman, Peter P. Toth, Sotirios Tsimikas, Paul E. Ziajka, Kevin C. Maki and Mary R. Dicklin

Journal of Clinical Lipidology 5 ( 5 ): 338 - 367 , 2011

Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia

Kevin C. Maki, Harold E. Bays, Mary R. Dicklin, Susan L. Johnson and Mayadah Shabbout

Journal of Clinical Lipidology 5 ( 6 ): 483 - 492 , 2011

Treatment options for the management of hypertriglyceridemia: Strategies based on the best-available evidence

Kevin C. Maki, Harold E. Bays and Mary R. Dicklin

Journal of Clinical Lipidology 6 ( 5 ): 413 - 426 , 2012